# Papillary Serous Carcinoma of the Endometrium

> **NCT00515073** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 30 (actual)

## Conditions studied

- Endometrial Cancer

## Interventions

- **DRUG:** Paclitaxel
- **RADIATION:** Pelvic Radiation
- **DRUG:** Dexamethasone
- **DRUG:** Cimetidine
- **DRUG:** Diphenhydramine

## Key facts

- **NCT ID:** NCT00515073
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-04
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2014-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00515073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00515073, "Papillary Serous Carcinoma of the Endometrium". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00515073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*